LAMEGOM 25 MG TBL FLM 84

What is the maximum co-payment for LAMEGOM?

If the insurance company contributes, the maximum co-payment is 2 946,16 Kč. The maximum pharmacy price is 3 692,96 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.

Does the medicine have reimbursement from public health insurance?

Yes, but check the specialization of the prescribing physician below (a so-called non-delegable prescription).

Does LAMEGOM have a counted co-payment set?

No, this medicine has no counted co-payment.

How much does the insurance company pay for one dispensed reimbursed pack?

746,80 Kč.

Does the insurance company pay a higher amount in some cases?

No, the medicine has no increased reimbursement.

Does the medicine have an indication restriction?

Léčba pacientů trpících depresivní poruchou (doprovázenou poruchami spánku či úzkostnými symptomy) bez dostatečné léčebné odpovědi na optimalizované dávky antidepresiv (při celkovém trvání léčby minimálně 6-8 týdnů) anebo při výskytu nežádoucích účinků, které vedou k nutnosti přerušení léčby předchozím antidepresivem. Léčba agomelatinem je ukončena u pacientů, u nichž po 2 měsících od zahájení léčby nedojde k objektivně prokazatelnému terapeutickému účinku.

Is it available without a medical prescription?

No, the medicine cannot be obtained without a prescription.

Which medical specialist may prescribe LAMEGOM?

psychiatry, child and adolescent psychiatry, geriatric psychiatry
neurology, pediatric neurology
sexology

What is the composition of LAMEGOM?

Agomelatin s kyselinou citronovou (44,739 mg), agomelatin (25 mg), neznámá látka s kódem 17625, mannitol, povidon k 30, koloidní bezvodý oxid křemičitý, neznámá látka s kódem 4987, neznámá látka s kódem 4174, magnesium-stearát, kyselina stearová, neznámá látka s kódem 14324, makrogol 6000, oxid titaničitý, ointmentek, žlutý oxid železitý. More information about the composition can be found in the SPC, section 6.1.

Where can I find information about correct use of the medicine?

Which medicines are similar to LAMEGOM?

The medicine belongs to ATC group N06AX22 – AGOMELATIN. Medicines with the same active substance can be found here.

Who manufactures LAMEGOM?

Krka, d.d., Novo mesto, Novo mesto (SLO)

Is the medicine in shortage?

The latest report from the manufacturer is from 20. 1. 2026. Production was terminated with effect from 1. 2. 2026. The manufacturer lists medicines with the following code as a potential substitute: